Zovirax tablets are taken by mouth, with or without food, for infections caused by herpes viruses. Treatment works best when started promptly after symptoms appear.
Zovirax tablets are taken by mouth, with or without food, for infections caused by herpes viruses. Treatment works best when started promptly after symptoms appear.
Zovirax tablets are taken by mouth, with or without food, for infections caused by herpes viruses. They contain acyclovir, an antiviral that interferes with viral DNA production in herpes simplex and varicella-zoster infections.
Zovirax may be prescribed for several herpes-virus conditions. The appropriate regimen depends on the diagnosis, immune status, kidney function, age, body weight, and whether the infection is a first episode, a recurrence, or a severe presentation.
| Condition | Main virus involved | Treatment goal |
|---|---|---|
| Cold sores and oral herpes | Herpes simplex virus | Limit viral multiplication and support faster lesion resolution |
| Genital herpes | Herpes simplex virus | Treat an episode or reduce recurrent episodes under a prescribed plan |
| Shingles | Varicella-zoster virus | Reduce viral activity and help limit the acute episode |
| Chickenpox | Varicella-zoster virus | Treat selected cases when antiviral therapy is clinically appropriate |
Cold sores often begin with tingling, burning, or itching before blisters appear. Starting treatment during this early phase can be more useful than waiting until lesions have fully developed.
Genital herpes may require episodic treatment during an outbreak or suppressive treatment when recurrences are frequent. Suppressive treatment reduces the number of outbreaks for some patients, but it does not eliminate transmission risk. Barrier protection and avoidance of sexual contact during active lesions remain relevant clinical measures. Transmission can occur without visible lesions. Medical advice can help reduce transmission risk.
Shingles produces a painful, usually one-sided rash in a band-like distribution. Facial involvement, eye symptoms, ear symptoms, widespread lesions, severe pain, or neurological symptoms need prompt medical assessment because complications can require specialist treatment.
The phrase “Cold Sore Cream” refers to a topical formulation rather than these oral tablets.
Oral Zovirax and topical antiviral treatment have different routes, dosing instructions, and clinical uses.
Zovirax contains acyclovir, an antiviral medicine in the nucleoside analogue class. It is used for susceptible herpes simplex virus infections and selected varicella-zoster virus infections, including genital herpes, cold sores, chickenpox, and shingles. Acyclovir reduces the ability of the virus to multiply; it does not remove the virus from the body.
The tablet is taken orally.
Food does not prevent acyclovir absorption, so it can generally be taken with meals or between meals. Adequate fluid intake is useful during oral treatment, especially in older adults or people with reduced kidney function.
After entering an infected cell, acyclovir is converted into its active triphosphate form through several phosphorylation steps. The first step depends mainly on a viral enzyme called thymidine kinase. This gives acyclovir greater activity in infected cells than in most uninfected cells.
The active form then inhibits viral DNA polymerase and can interrupt the growing viral DNA chain. Viral replication slows, which may shorten the duration or reduce the severity of an outbreak when treatment begins early. Zovirax does not cure latent herpes infection, so the virus can remain inactive in nerve tissue and reactivate later [1].
A practical point is easy to miss: acyclovir works against viral replication, not against pain alone. A person may still need separate advice for discomfort, fever, or skin care while the antiviral treatment addresses the infection itself.
Zovirax acts after activation inside virus-infected cells. Its active metabolite inhibits viral DNA polymerase, while the body’s own DNA polymerase is affected much less at therapeutic exposure. The result is selective suppression of herpes-virus replication rather than a direct destruction of every infected cell.
The exact Zovirax tablet regimen for the chosen strength must be confirmed with a healthcare professional before starting. Acyclovir schedules differ according to the infection, treatment purpose, kidney function, immune status, age, and body weight.
The dose for children is calculated differently from the dose for adults and may depend on body weight. Kidney impairment can require a longer interval or a reduced amount because acyclovir is cleared mainly through the kidneys. Dehydration increases the risk of kidney-related adverse effects.
Acyclovir treatment is most useful when started early. For cold sores and genital herpes, early symptoms such as tingling, burning, itching, or new blisters can be clinically relevant. For shingles, prompt treatment matters because delayed antiviral therapy may provide less benefit, especially when complications are possible.
Do not crush, chew, or split a tablet unless the prescribed product and clinical instructions specifically allow it. Altering a solid oral dosage form can make swallowing difficult and may lead to an inaccurate dose.
Zovirax acts after activation inside virus-infected cells. Its active metabolite inhibits viral DNA polymerase, while the body’s own DNA polymerase is affected much less at therapeutic exposure. The result is selective suppression of herpes-virus replication rather than a direct destruction of every infected cell.
| Approach | Main active principle | Practical distinction |
|---|---|---|
| Zovirax tablets | Acyclovir | Oral antiviral therapy for selected herpes simplex and varicella-zoster infections |
| Prodrug approach | Valacyclovir | Converted to acyclovir in the body and may allow less frequent administration in some regimens |
| Supportive treatment alone | Pain relief and skin care | Helps symptoms but does not directly inhibit viral DNA replication |
Acyclovir and valacyclovir are pharmacologically related, but they are not interchangeable tablet-for-tablet. The chosen option depends on the infection, renal function, adherence considerations, treatment history, and prescribing judgment.
Antibiotics do not treat herpes simplex or varicella-zoster viruses. They may be used only when a separate bacterial infection develops, such as bacterial infection of damaged skin.
Several avoidable mistakes can reduce the benefit of treatment or increase risk:
One detail patients often overlook is the difference between a recurrence and a first episode. A first genital herpes episode can be more extensive and may need a different clinical approach from a familiar, brief recurrence.
Another common error is confusing pain relief with antiviral treatment. Pain may improve while viral replication continues, or lesions may begin healing while nerve pain persists. These symptoms should be assessed separately.
The main contraindication is a known serious hypersensitivity to acyclovir, valacyclovir, or an excipient in the prescribed formulation.
Kidney function deserves attention because acyclovir is eliminated through the kidneys. Older adults, people with chronic kidney disease, and those taking other medicines that may affect renal function may need clinical monitoring and a modified regimen. The WHO identifies renal dosing and hydration as important safety considerations for medicines cleared predominantly through the kidneys [2].
Tell the prescriber about kidney disease, neurological disease, immune suppression, pregnancy, breastfeeding, and all medicines being used. Medicines that can affect kidney function may increase the need for monitoring. The risk is not determined only by the tablet strength; it also depends on the patient’s physiology and the treatment schedule.
Zovirax does not prevent all transmission of genital herpes. Lesions may remain infectious while healing, and asymptomatic viral shedding can occur. Treatment decisions should include sexual-health advice when genital herpes is involved.
Many people tolerate oral acyclovir without serious problems. Reported adverse effects include headache, nausea, vomiting, diarrhoea, abdominal discomfort, tiredness, dizziness, and skin reactions. The likelihood can rise when renal clearance is reduced or when the person becomes dehydrated.
Common practical problems include:
Taking the tablet with food may make stomach discomfort easier for some people, even though food is not required for absorption. A rash should not automatically be dismissed as part of the viral infection, especially if it spreads quickly or affects the mouth, eyes, or throat.
Rare but serious reactions include confusion, hallucinations, tremor, seizures, severe drowsiness, reduced urine output, and acute kidney injury. Neuropsychiatric reactions are more likely in older adults and people with impaired kidney function. Very low urine volume, sudden confusion, or severe weakness requires urgent assessment.
Severe allergic reactions can include facial or throat swelling, breathing difficulty, blistering skin, or extensive peeling. These symptoms require emergency care.
Topical irritation applies to cream preparations and should not be assumed to describe the tablet formulation. Oral tablets can still cause generalised skin reactions, including rare severe reactions.
Clinicians generally view acyclovir as most useful when the diagnosis is clear and treatment begins early. A cold sore, genital lesion, shingles rash, and chickenpox can look different, so the same tablet schedule is not suitable for every presentation.
Doctors also assess the purpose of treatment. An isolated cold sore may need a short episodic regimen, while frequent genital herpes recurrences may lead to discussion of suppressive therapy. Shingles involving the eye, face, ear, or nervous system needs rapid medical assessment rather than self-directed treatment.
A physician would also consider whether the illness is uncomplicated. Immunocompromised patients may have more extensive disease, prolonged viral shedding, or a higher risk of complications. In those cases, oral treatment may not be sufficient and further evaluation may be required.
The clinical benefit is usually measured by reduced lesion progression, shorter episode duration, reduced viral activity, or fewer recurrences. Acyclovir does not guarantee that every outbreak will stop immediately, and residual pain or skin sensitivity may continue after viral replication has declined. MHRA product information describes these distinctions between antiviral activity, symptom improvement, and recurrence prevention [3].
Nausea is a recognised adverse effect of oral acyclovir, along with vomiting, diarrhoea, headache, and abdominal discomfort. FDA prescribing information reviewed in 2025 lists gastrointestinal symptoms among reported reactions to systemic acyclovir. Taking a dose with food may reduce stomach discomfort for some people, but persistent vomiting can contribute to dehydration and needs medical attention.
Acyclovir may be considered during pregnancy when the expected clinical benefit justifies treatment, and the decision depends on the infection and the patient’s circumstances. The NHS and EMA information available in 2025 describe acyclovir as a medicine that may be prescribed during pregnancy when clinically indicated. Acyclovir passes into breast milk in small amounts, so breastfeeding decisions should account for the maternal infection, infant age, and prescribed regimen.
Take the missed dose when remembered unless the next dose is close. If the next scheduled dose is near, skip the missed dose and continue at the usual time; do not take two doses together. Clinical dosing principles in the WHO Model Formulary (2008) support avoiding dose doubling because it does not reliably restore antiviral exposure and may increase adverse effects.
Older adults can receive acyclovir when it is clinically appropriate, but kidney function and hydration deserve close attention. The American Geriatrics Society guidance available in 2023 supports careful medication review in older adults because reduced renal clearance can increase exposure to renally eliminated medicines. New confusion, unusual drowsiness, tremor, or reduced urine output should prompt urgent assessment.
Discuss kidney disease, dehydration, pregnancy, breastfeeding, immune suppression, neurological conditions, previous reactions to acyclovir or valacyclovir, and all current medicines. MOHAP guidance on prescription medicines in the UAE from 2024 emphasises the importance of relevant medical history when treatment may require dose adjustment. Mention whether the rash is a first episode, a recurrence, painful, widespread, or near the eye.
Children and adolescents may be prescribed acyclovir for selected infections, but the regimen depends on age, body weight, diagnosis, and kidney function. Paediatric dosing principles in the 2024 British National Formulary for Children require an age-appropriate or weight-based approach rather than simply using an adult schedule. A child with chickenpox, widespread lesions, dehydration, or a weakened immune system needs prompt clinical assessment.
Emergency assessment is needed for breathing difficulty, facial or throat swelling, blistering or peeling skin, severe widespread rash, confusion, hallucinations, seizures, fainting, or a major reduction in urine output. These symptoms may indicate a severe allergic reaction, neurological toxicity, or kidney injury. The FDA safety information reviewed in 2025 identifies serious hypersensitivity, neurological reactions, and renal complications as reasons for urgent evaluation.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
